Close
ACHEMA MIDDLE EAST 2026

Hong Kong On The Way To Become Microbiome Hub For APAC

To host the Microbiome Summit 2023 at the Hong Kong Science Park, the medicine faculty of the Chinese University of Hong Kong, Hong Kong...

UK Offering An Ideal Ecosystem For ATMP Clinical Trials

The UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 has been published by Cell and Gene Therapy (CGT). T cells were said to...

U.S. To List Out 10 Prescription Drugs To Negotiate Prices

A senior Biden White House official said on January 11 that the U.S. administration will provide a list of the ten prescription pharmaceuticals for...

2023 Will See Inflation A Cause of Worry For Global Pharma

As the high inflation threat is on the subsiding verge, the second-round effects may not go away quickly. Pharma may have to go through...

Addressing The Antibiotic Shortage Challenge Across Europe

According to Stella Kyriakides, the EU Health Commissioner, the thought about changes to EU pharmaceutical law shall have robust obligations for medicine supply and...

Detection of High-Risk Patients By Aortic Stability Testing

According to a recent study conducted in collaboration by the University of Eastern Finland and Kuopio University Hospital, patients with ascending aortic dilatation are...

The FDA Has Finalized Its Prescription Drug REMS Guidelines

The FDA's Final Guidance on REMS programmes for prescription medications, has just been published. The document is officially titled Format and Content of a...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...